thetaOwl

TSLA

Tesla, Inc.Close $445.27EOD only
Max Pain
$400.00
Next expiry May 15, 2026
Expected Move
±$15.50
3.5% from close
Price Gap
-45.27
Distance to max pain
IV Rank
86
High premium
P/C OI
0.76
Slightly call-heavy
Consensus
8.5/10
Bullish tilt
Published snapshot: May 13, 2026 close
End-of-day snapshot

This page reflects TSLA options positioning from the latest published market-close snapshot. Intraday price and contract changes are not displayed.

Published Snapshot
May 13, 2026 close
TSLA AI Consensus Report
Analysis based on market close May 14, 2026

Historical consensus-supported lens with full content, report chain context, and metric rail.

Conviction
7.0

out of 10

7 not 8 because the pin risk from spot being far above max pain and the conflicting short-term structures (theta selling vs. bullish continuation) reduce certainty.

Where Perspectives Agree

Bullish bias with dealer gamma support and institutional call flow dominance, but caution warranted as spot is 9.5% above max pain and heavy put hedging may cap upside.

Where They Diverge

Theta's strategy of selling call spreads relies on price staying below $460, while directional and flow see potential for upside beyond that level, conflicting with the defined-risk income approach.

Top Trade
via directional

Buy 2026-07-17 $455/$510 bull call spread for $12.50 debit

Key Risk

Break below $410 flips dealer gamma to long, removing support and triggering a decline to $395 gap fill.

How to Use These Reports
This ai consensus reflects the market close on May 14, 2026.
What the reports do

Each report translates the same market-close options snapshot into a specific lens such as directional bias, premium-selling posture, flow quality, or earnings setup.

How traders use them

Reports are most useful for narrowing the playbook, surfacing entry and risk context, and deciding which raw data page to inspect next.

What to remember

These are interpretation layers, not execution guarantees. Validate the setup against chain liquidity, expected move, and exposure before sizing risk.

If the report conviction and the raw data disagree, slow down and resolve the mismatch before sizing risk.